Active Ingredient(s): Pramlintide
FDA Approved: * March 16, 2005
Pharm Company: * AMYLIN
Category: Diabetes

Pramlintide (trade name Symlin) is an injectable amylin analogue drug for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca).[1] Pramlintide is sold as an acetate salt. Contents 1 Pharmacology 2 Approval 3 Design and structure 4 References 5 External links Pharmacology Pramlintide is an analogue of amylin, a small peptide hormone that is released into the bloodstream by the β cells of the pancreas along ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Symlin 600 ug/ml Subcutaneous Injection
NDC: 66780-110
Amylin Pharmaceuticals, Inc.

Popular Topics


to lower blood sugar...

cost of Symlin

Symlin (pramlintide acetate) injection 0.6mg/ml. 5ml.VGial...

others taking symlin

I'd like to chat with others who are taking symlin along with insulin...